Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses

Cites (282)

Items 201–283 of 283

1. Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis
   Mohamad J. Alshikho, Nicole R. Zürcher, Marco L. Loggia, Paul Cernasov, Daniel B. Chonde, David Izquierdo‐Garcia, Julia E. Yasek, Oluwaseun Akeju, Ciprian Catana, Bruce Robert Rosen et al. · 2016 · Neurology
2. Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis
   Seiitsu Ono, Jianguo Hu, Natsue Shimizu, Takashi Imai, Hachiro Nakagawa · 2001 · Journal of the Neurological Sciences
3. TRANSFORMING GROWTH FACTOR-BETA 1 (TGF-BETA 1) IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS
   Joanna Iłżecka, Zbigniew Stelmasiak, Beata Dobosz · 2002 · Cytokine
4. Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis?
   Gille, Benjamin, De Schaepdryver, Maxim, Dedeene, Lieselot, Goossens, Janne, Claeys, Kristl G, Van Den Bosch, Ludo, Tournoy, Jos, Van Damme, Philip, Poesen, Koen · 2019 · Journal of Neurology, Neurosurgery & Psychiatry
5. Innate immunity in inflammatory bowel disease: a disease hypothesis
   D.J.B. Marks, Anthony Walter Segal · 2007 · The Journal of Pathology
6. Optineurin Insufficiency Impairs IRF3 but Not NF-κB Activation in Immune Cells
   Ivana Munitić, Maria Letizia Giardino Torchia, Netra Pal Meena, Guozhi Zhu, Caiyi C. Li, Jonathan D. Ashwell · 2013 · The Journal of Immunology
7. Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis
   Xin Fang · 2015 · International Journal of Neuroscience
8. Heterozygous <i>Tbk1</i> loss has opposing effects in early and late stages of ALS in mice
   Brenner, David, Sieverding, Kirsten, Bruno, Clara, Lüningschrör, Patrick, Buck, Eva, Mungwa, Simon, Fischer, Lena, Brockmann, Sarah J., Ulmer, Johannes, Bliederhäuser, Corinna et al. · 2019 · Journal of Experimental Medicine
9. Follow‐up evaluation of cognitive function in the randomized Alzheimer's Disease Anti‐inflammatory Prevention Trial and its Follow‐up Study
   ADAPT-FS Research Group · 2014 · Alzheimer s & Dementia
10. Optineurin deficiency in mice is associated with increased sensitivity to Salmonella but does not affect proinflammatory NF‐κB signaling
    Karolina Slowicka, Lars Vereecke, Conor Mc Guire, Mozes Sze, Jonathan Maelfait, Annasaheb B. Kolpe, Xavier Saelens, Rudi Beyaert, Geert Loo · 2015 · European Journal of Immunology
11. CYLD is a causative gene for frontotemporal dementia – amyotrophic lateral sclerosis
    Carol Dobson‐Stone, Marianne Hallupp, Hamideh Shahheydari, Audrey Ragagnin, Zac Chatterton, Francine Carew‐Jones, Claire E. Shepherd, Holly Stefen, Esmeralda Parić, Thomas Fath et al. · 2020 · Brain
12. Neurodegeneration and <scp>NLRP3</scp> inflammasome expression in the anterior thalamus of <scp>SOD1(G93A) ALS</scp> mice
    Debye, Berthold, Schmülling, Lena, Zhou, Lepu, Rune, Gabriele, Beyer, Cordian, Johann, Sonja · 2018 · Brain Pathology
13. T helper-17 activation dominates the immunologic milieu of both amyotrophic lateral sclerosis and progressive multiple sclerosis
    Marina Saresella, Federica Piancone, Paola Tortorella, Ivana Marventano, Andrea Valer Gatti, Domenico Caputo, Christian Lunetta, Massimo Corbo, Marco Rovaris, Mario Clerici · 2013 · Clinical Immunology
14. Cross-sectional and longitudinal measures of chitinase proteins in amyotrophic lateral sclerosis and expression of CHI3L1 in activated astrocytes
    Lucas T. Vu, Jiyan An, Tina Kovalik, Tania F. Gendron, Leonard Petrucelli, Robert P. Bowser · 2020 · Journal of Neurology Neurosurgery & Psychiatry
15. The Golgi apparatus acts as a platform for TBK1 activation after viral RNA sensing
    Marie Pourcelot, Naïma Zemirli, Leandro Silva da Costa, Roxane Loyant, Dominique Garcin, Damien Vitour, Ivana Munitić, Aimé Vázquez, Damien Arnoult · 2016 · BMC Biology
16. Influence of Normal Aging on Brain Autophagy: A Complex Scenario
    David A. Loeffler · 2019 · Frontiers in Aging Neuroscience
17. CX3CR1 Is a Modifying Gene of Survival and Progression in Amyotrophic Lateral Sclerosis
    A López-López, Josep Gámez, Emilio Syriani, Miguel Morales, María Salvadó, Manuel José Rodríguez, Nicole Mahy, Jose Manuel Vidal-Taboada · 2014 · PLoS ONE
18. Spinal but not cortical microglia acquire an atypical phenotype with high VEGF, galectin-3 and osteopontin, and blunted inflammatory responses in ALS rats
    Mária Nikodémová, Alissa L. Small, Stephanie M. C. Smith, Gordon S. Mitchell, Jyoti J. Watters · 2013 · Neurobiology of Disease
19. Comparison of the growth hormone, IGF‐1 and insulin in cerebrospinal fluid and serum between patients with motor neuron disease and healthy controls
    Ervina Bilić, Ervina Bilić, Igor Rudan, Vesna Kuŝec, Niko Zurak, Domagoj Delimar, Marija Žagar · 2006 · European Journal of Neurology
20. High neutrophil-to-lymphocyte ratio predicts short survival duration in amyotrophic lateral sclerosis
    Seok‐Jin Choi, Yoon‐Ho Hong, Sung‐Min Kim, Je-Young Shin, Young Ju Suh, Jung‐Joon Sung · 2020 · Scientific Reports
21. Immune response in peripheral axons delays disease progression in SOD1G93A mice
    Giovanni Nardo, Maria Chiara Trolese, Giuseppe de Vito, Roberta Cecchi, Nilo Riva, Giorgia Dina, Paul Roy Heath, Angelo Quattrini, Pamela J. Shaw, Vincenzo Piazza et al. · 2016 · Journal of Neuroinflammation
22. Increased IL-13-producing T cells in ALS: Positive correlations with disease severity and progression rate
    Nan Shi, Yuji Kawano, Takahisa Tateishi, Hitoshi Kikuchi, Manabu Osoegawa, Yasumasa Ohyagi, Jun‐ichi Kira · 2006 · Journal of Neuroimmunology
23. Receptor for Advanced Glycation End Products and its Inflammatory Ligands are Upregulated in Amyotrophic Lateral Sclerosis
    Juranek, Judyta K., Daffu, Gurdip K., Wojtkiewicz, Joanna, Lacomis, David, Kofler, Julia, Schmidt, Ann Marie · 2015 · Frontiers in Cellular Neuroscience
24. Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model
    Jingjing Zhang, Yufei Liu, Xinyao Liu, Song Li, Cheng Cheng, Sheng Chen, Weidong Le · 2018 · Translational Neurodegeneration
25. Ubiquilin-2 drives NF-κB activity and cytosolic TDP-43 aggregation in neuronal cells
    Picher-Martel, Vincent, Dutta, Kallol, Phaneuf, Daniel, Sobue, Gen, Julien, Jean-Pierre · 2015 · Molecular Brain
26. Increased plasma TGF-β1 in patients with amyotrophic lateral sclerosis
    Kouji Houi, T. Kobayashi, Shigeaki Kato, S. Mochio, K Inoue · 2002 · Acta Neurologica Scandinavica
27. Passive transfer of purified IgG from patients with amyotrophic lateral sclerosis to mice results in degeneration of motor neurons accompanied by Ca 2+ enhancement
    A. H. Pullen, Maria Demestre, Robin Howard, Richard W. Orrell · 2003 · Acta Neuropathologica
28. Primary Immunodeficiencies and Inflammatory Disease: A Growing Genetic Intersection
    Nassima Fodil, David Langlais, Philippe Gros · 2016 · Trends in Immunology
29. Innate immune adaptor TRIF deficiency accelerates disease progression of ALS mice with accumulation of aberrantly activated astrocytes
    Okiru Komine, Hirofumi Yamashita, Noriko Fujimori-Tonou, Masato Koike, Shijie Jin, Yasuhiro Moriwaki, Fumito Endo, Seiji Watanabe, Satoshi Uematsu, Shizuo Akira et al. · 2018 · Cell Death and Differentiation
30. CSF cytokine profile distinguishes multifocal motor neuropathy from progressive muscular atrophy
    Takahiro Furukawa, Naoko Matsui, Koji Fujita, Hiroyuki Nodera, Fumitaka Shimizu, Katsuichi Miyamoto, Yukitoshi Takahashi, Takashi Kanda, Susumu Kusunoki, Yuishin Izumi et al. · 2015 · Neurology Neuroimmunology & Neuroinflammation
31. Evaluating the levels of CSF and serum factors in ALS
    Jie Fang Guo, Xuan Yang, Lina Gao, Dawei Zang · 2017 · Brain and Behavior
32. Autoimmunity in Amyotrophic Lateral Sclerosis: Past and Present
    Mario Rafael Pagani, Laura Elisabeth Gonzalez, Osvaldo Daniel Uchitel · 2011 · Neurology Research International
33. ALS-Associated E478G Mutation in Human OPTN (Optineurin) Promotes Inflammation and Induces Neuronal Cell Death
    Zhengzhao Liu, Hongming Li, Chun‐Gu Hong, Menglu Chen, Tao Yue, Chunyuan Chen, Zhen‐Xing Wang, Qing You, Chuanyin Li, Qinjie Weng et al. · 2018 · Frontiers in Immunology
34. Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis
    Mads Nikolaj Olesen, Anna Wuolikainen, Anna Christine Nilsson, Martin Wirenfeldt, Karin Forsberg, Jonna Skov Madsen, Søren Thue Lillevang, Ivan Brandslund, Peter Munch Andersen, Nasrin Asgari · 2020 · Neurology Neuroimmunology & Neuroinflammation
35. Disruption of macrophage pro‐inflammatory cytokine release in C rohn's disease is associated with reduced optineurin expression in a subset of patients
    Andrew Mark Smith, Gavin W. Sewell, Adam P. Levine, Thean Soon Chew, Jenny Dunne, Nuala R. O’Shea, Philip J Smith, Penelope J. Harrison, C MacDonald, Stuart L Bloom et al. · 2014 · Immunology
36. Transforming Growth Factor-β Signaling in Motor Neuron Diseases
    Masahisa Katsuno, Hiroaki Adachi, Haruhiko Banno, Keisuke Suzuki, Fumiaki Tanaka, Gen Sobue · 2011 · Current Molecular Medicine
37. Phenotypic transition of microglia into astrocyte-like cells associated with disease onset in a model of inherited ALS
    Emiliano Trías, Pablo Díaz‐Amarilla, Silvia Olivera‐Bravo, Eugenia Isasi, Derek A. Drechsel, Nathan I. Lopez, C. Samuel Bradford, Kyle E. Ireton, Joseph S. Beckman, Luis Barbeito · 2013 · Frontiers in Cellular Neuroscience
38. Smoking and amyotrophic lateral sclerosis: A mendelian randomization study
    Zhan, Yiqiang, Fang, Fang · 2019 · Annals of Neurology
39. Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis
    Juan Liu, Lina Gao, Dawei Zang · 2015 · PLoS ONE
40. Adult obese mice suffer from chronic secondary brain injury after mild TBI
    Matthew Sherman, Mingmei Liu, Shari G. Birnbaum, Steven E. Wolf, Joseph P. Minei, Joshua W. Gatson · 2016 · Journal of Neuroinflammation
41. Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability
    James D. Berry, Sabrina Paganoni, Nazem Atassi, Eric A. Macklin, Namita Goyal, Michael H. Rivner, Ericka P. Simpson, Stanley H. Appel, Daniela Grasso, Nicte I. Mejia et al. · 2017 · Muscle & Nerve
42. Optineurin deficiency contributes to impaired cytokine secretion and neutrophil recruitment in bacteria driven colitis
    Thean Soon Chew, Nuala R. O’Shea, Gavin W. Sewell, Stefan H. Oehlers, Claire M. Mulvey, Philip S. Crosier, Jasminka Godovac‐Zimmermann, Stuart L Bloom, Andrew Mark Smith, Anthony Walter Segal · 2015 · Disease Models & Mechanisms
43. History of Innate Immunity in Neurodegenerative Disorders
    Patrick L. McGeer, Edith G. McGeer · 2011 · Frontiers in Pharmacology
44. Endothelial and Astrocytic Support by Human Bone Marrow Stem Cell Grafts into Symptomatic ALS Mice towards Blood-Spinal Cord Barrier Repair
    Svitlana N. Garbuzova-Davis, Crupa Kurien, Avery Thomson, Dimitri Falco, Sohaib Ahmad, Joseph F. Staffetti, George A. Steiner, Sophia Abraham, G. V. James, Ajay Mahendrasah et al. · 2017 · Scientific Reports
45. Effects of ALS-associated TANK binding kinase 1 mutations on protein–protein interactions and kinase activity
    Junqiang Ye, Jonah Cheung, Valeria Gerbino, Göran Ahlsén, Christina M. Zimanyi, David Hirsh, Tom Maniatis · 2019 · Proceedings of the National Academy of Sciences
46. Tocilizumab infusion therapy normalizes inflammation in sporadic ALS patients.
    Milan Fiala, Mathew T. Mizwicki, Rachel E. Weitzman, Larry I. Magpantay, Norihiro Nishimoto · 2013 · Europe PMC (PubMed Central)
47. Antiviral Immune Response as a Trigger of FUS Proteinopathy in Amyotrophic Lateral Sclerosis
    Tatyana A. Shelkovnikova, Haiyan An, Lucy Skelt, John S. Tregoning, Ian Robert Humphreys, Vladimir L. Buchman · 2019 · Cell Reports
48. A dual role for microglia in promoting tissue inhibitor of metalloproteinase (TIMP) expression in glial cells in response to neuroinflammatory stimuli
    Jennifer V. Welser-Alves, Stephen J. Crocker, Richard Milner · 2011 · Journal of Neuroinflammation
49. Advances in stem cell therapy for amyotrophic lateral sclerosis
    Letizia Mazzini, Daniela Ferrari, Pavle R. Anđjus, Leonora Bużańska, Roberto M. Cantello, Fabiola De Marchi, Maurizio Gelati, Rashid A. Giniatullin, Joel Clinton Glover, Mariagrazia Grilli et al. · 2018 · Expert Opinion on Biological Therapy
50. Development of ALS-like disease in SOD-1 mice deficient of B lymphocytes
    Shulamit Naor, Keren Zohar, Tomer Bronshtein, Efrat Goren, Marcelle Machluf, Doron Melamed · 2009 · Journal of Neurology
51. Deletion of Ripk3 Prevents Motor Neuron Death In Vitro but not In Vivo
    Georgia Dermentzaki, Kristin A. Politi, Lei Lü, Vartika R. Mishra, Eduardo J. Pérez-Torres, Alexander A. Sosunov, Guy M. McKhann, Francesco Lotti, Neil A. Shneider, Serge Przedborski · 2019 · eNeuro
52. Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with<i>C9orf72</i>hexanucleotide repeat expansion
    Barschke, Peggy, Oeckl, Patrick, Steinacker, Petra, Al Shweiki, MHD Rami, Weishaupt, Jochen H, Landwehrmeyer, G Bernhard, Anderl-Straub, Sarah, Weydt, Patrick, Diehl-Schmid, Janine, Danek, Adrian et al. · 2020 · Journal of Neurology, Neurosurgery &amp; Psychiatry
53. I’ve Gut A Feeling: Microbiota Impacting the Conceptual and Experimental Perspectives of Personalized Medicine
    Amedeo Amedei, Federico Boem · 2018 · International Journal of Molecular Sciences
54. Peripheral nerve inflammation in ALS mice: cause or consequence
    Osamu Kano, David R. Beers, J. Henkel-Tigges, Stanley H. Appel · 2012 · Neurology
55. The TBK 1‐binding domain of optineurin promotes type I interferon responses
    Netra Pal Meena, Guozhi Zhu, Paul R. Mittelstadt, Maria Letizia Giardino Torchia, Marie Pourcelot, Damien Arnoult, Jonathan D. Ashwell, Ivana Munitić · 2016 · FEBS Letters
56. Infectious agents and amyotrophic lateral sclerosis: another piece of the puzzle of motor neuron degeneration
    Castanedo-Vazquez, David, Bosque-Varela, Pilar, Sainz-Pelayo, Arancha, Riancho, Javier · 2019 · Journal of Neurology
57. Inflammatory role of dendritic cells in Amyotrophic Lateral Sclerosis revealed by an analysis of patients’ peripheral blood
    Michela Rusconi, Francesca Gerardi, William Santus, Andrea Lizio, Valeria Sansone, Christian Lunetta, Ivan Zanoni, Francesca Granucci · 2017 · Scientific Reports
58. Human Bone Marrow Endothelial Progenitor Cell Transplantation into Symptomatic ALS Mice Delays Disease Progression and Increases Motor Neuron Survival by Repairing Blood-Spinal Cord Barrier
    Svitlana N. Garbuzova-Davis, Crupa Kurien, Edward M. Haller, David J. Eve, Stephanie Navarro, George A. Steiner, Ajay Mahendrasah, Surafuale Hailu, Mohammed Khatib, Kayla J. Boccio et al. · 2019 · Scientific Reports
59. Highly Immunoreactive IgG Antibodies Directed against a Set of Twenty Human Proteins in the Sera of Patients with Amyotrophic Lateral Sclerosis Identified by Protein Array
    Caroline May, Eckhard Nordhoff, Swaantje Casjens, Michael Turewicz, Martin Eisenacher, Ralf Gold, Thomas Brüning, Beate Pesch, Christian Stephan, Dirk Woitalla et al. · 2014 · PLoS ONE
60. Thymic involution, a co‐morbidity factor in amyotrophic lateral sclerosis
    Akop Seksenyan, Noga Ron‐Harel, David Azoulay, Liora Cahalon, Michal Cardon, Patrícia Soares Rogeri, MinHee K. Ko, Miguel Weil, Shlomo Bulvik, Gideon Rechavi et al. · 2009 · Journal of Cellular and Molecular Medicine
61. Tumor Necrosis Factor Alpha Enhances Glutamatergic Transmission onto Spinal Motoneurons
    Pengcheng Han, Patrick J. Whelan · 2009 · Journal of Neurotrauma
62. Detection of enteroviral sequences from frozen spinal cord samples of Japanese ALS patients
    Pierric Giraud, Frédérik Beaulieux, S. Ono, Natsue Shimizu, Guy Chazot, Bruno Lina · 2001 · Neurology
63. PL‐03‐01: Microinfarcts: Key to prevention of the vascular burden in dementia?
    Geert Jan Biessels · 2015 · Alzheimer s & Dementia
64. Enteroviral Infection Leads to Transactive Response DNA-Binding Protein 43 Pathology in Vivo
    Yuan Chao Xue, Chelsea M. Ruller, Gabriel Fung, Yasir Mohamud, Haoyu Deng, Huitao Liu, Jingchun Zhang, Ralph Feuer, Honglin Luo · 2018 · American Journal Of Pathology
65. Nuclear factor ? B expression in patients with sporadic amyotrophic lateral sclerosis and hereditary amyotrophic lateral sclerosis with optineurin mutations
    Sako, Wataru, Ito, Hidefumi, Yoshida, Mari, Koizumi, Hidetaka, Kamada, Masaki, Fujita, Koji, Hashizume, Yoshio, Izumi, Yuishin, Kaji, Ryuji · 2012 · Clinical Neuropathology
66. HIV-1 clade-C-associated “ALS”-like disorder: first report from India
    Sanjib Sinha, Thomas Mathews, G.R. Arunodaya, Nagadenahalli Byrareddy Siddappa, Udaykumar Ranga, Anita Sudhir Desai, Vasanthapuram Ravi, A B Taly · 2004 · Journal of the Neurological Sciences
67. Novel Molecular Biomarkers at the Blood-Brain Barrier in ALS
    Danijela Bataveljić, Milena M. Milosevic, Lidija Radenović, Pavle R. Anđjus · 2014 · BioMed Research International
68. Lysosomal degradation of depolarized mitochondria is rate-limiting in OPTN-dependent neuronal mitophagy
    Chantell S. Evans, Erika L.F. Holzbaur · 2020 · Autophagy
69. Common polymorphisms of chemokine (C‐X3‐C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population‐based study
    Andrea Calvo, Cristina Moglia, Antonio Canosa, Stefania Cammarosano, Antonio Ilardi, Davide Bertuzzo, Bryan J. Traynor, Maura Brunetti, Marco Barberis, Gabriele Mora et al. · 2017 · Muscle & Nerve
70. Inflammation, immunity, and amyotrophic lateral sclerosis: II. immune‐modulating therapies
    Marlena Wosiski‐Kuhn, Miles S. Lyon, James B. Caress, Carol Milligan · 2018 · Muscle & Nerve
71. IL6 receptor 358 Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis
    Marlena Wosiski‐Kuhn, Mac Robinson, Jane L. Strupe, Phonepasong Arounleut, Matthew Martin, James B. Caress, Michael S. Cartwright, Robert P. Bowser, Merit Cudkowicz, Carl D. Langefeld et al. · 2019 · Neurology Neuroimmunology & Neuroinflammation
72. Optineurin Insufficiency Disbalances Proinflammatory and Anti-inflammatory Factors by Reducing Microglial IFN-β Responses
    Andrea Markovinović, Tereza Ljutić, Louis‐Charles Béland, Ivana Munitić · 2018 · Neuroscience
73. Potential skin involvement in ALS: revisiting Charcot’s observation – a review of skin abnormalities in ALS
    Bastien Paré, François Gros‐Louis · 2017 · Reviews in the Neurosciences
74. Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer’s Disease
    Robert Weißmann, Melanie Hüttenrauch, Tim Kacprowski, Yvonne Bouter, Laurent Pradier, Thomas A. Bayer, Andreas Walter Kuss, Oliver Wirths · 2016 · Journal of Alzheimer s Disease
75. Inflammatory and non-inflammatory monocytes as novel prognostic biomarkers of survival in SOD1G93A mouse model of Amyotrophic Lateral Sclerosis
    Samanta Gasco, P. Zaragoza, Alberto García‐Redondo, Ana Cristina Calvo, Rosario Osta · 2017 · PLoS ONE
76. HIV-related neuromuscular diseases: nemaline myopathy, amyotrophic lateral sclerosis and bibrachial amyotrophic diplegia.
    Lewis P. Rowland · 2011 · Europe PMC (PubMed Central)
77. Immunoglobulins G from Sera of Amyotrophic Lateral Sclerosis Patients Induce Oxidative Stress and Upregulation of Antioxidative System in BV-2 Microglial Cell Line
    Milena M. Milosevic, Katarina D. Milicevic, Iva D. Bozic, Irena C. Lavrnja, Ivana D. Stevanović, Dunja D. Bijelić, Marija Dubaić, Irena P. Zivkovic, Zorica Stević, Rashid A. Giniatullin et al. · 2017 · Frontiers in Immunology
78. Mutant SOD1 prevents normal functional recovery through enhanced glial activation and loss of motor neuron innervation after peripheral nerve injury
    Sarah Schram, Donald Chuang, Greg Schmidt, Hristo Piponov, Cory W. Helder, James M. Kerns, Mark H. Gonzalez, Fei Song, Jeffrey A. Loeb · 2018 · Neurobiology of Disease
79. Glia in amyotrophic lateral sclerosis and spinal cord injury: common therapeutic targets
    Jelena Ban, Cynthia Sámano, Miranda Mladinić, Ivana Munitić · 2019 · Croatian Medical Journal
80. Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-α, IL-6, and IL-10 in the spinal cord and serum of mice
    Izabella Obál, Gergely Klausz, Yvette Mándi, Mária A. Deli, László Siklós, József I. Engelhardt · 2016 · Journal of Neuroinflammation
81. Transforming growth factor-β plasma levels and its role in amyotrophic lateral sclerosis
    Tatiana Duque, Marta Gromicho, Ana Catarina Pronto‐Laborinho, Mamede A. de Carvalho · 2020 · Medical Hypotheses
82. Attenuation of ALS progression during pregnancy—lessons to be learned or just a coincidence?
    Mirea Hančević, Hrvoje Bilić, Barbara Sitaš, Gordana Pavliša, Fran Borovečki, Ivana Munitić, Ervina Bilić · 2019 · Neurological Sciences
83. Alzheimer’s Disease of the Immune System: A New Variant of Immune Deficiency
    Isaac Melamed · 2016 · Immunotherapy Open Access